Home » Inspire’s Dry Eye Treatment Fails Late-Stage Study
Inspire’s Dry Eye Treatment Fails Late-Stage Study
Biotechnology company Inspire Pharmaceuticals Inc. said Thursday its drug candidate for dry eye disease failed to meet key treatment goals in a late-stage
study.
SanLuisObispo
SanLuisObispo
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May